Beneficial actions of neurotrophin treatment on diabetes-induced hypoalgesia in mice
- 1 November 2003
- journal article
- research article
- Published by Elsevier in The Journal of Pain
- Vol. 4 (9) , 493-504
- https://doi.org/10.1016/j.jpain.2003.07.002
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Low serum levels of nerve growth factor in diabetic neuropathyActa Neurologica Scandinavica, 2009
- GDNF Rescues Nonpeptidergic Unmyelinated Primary Afferents in Streptozotocin-Treated Diabetic MiceExperimental Neurology, 2001
- Localization of unmyelinated axons in rat skin and mucocutaneous tissue utilizing the isolectin GS-I-BSomatosensory & Motor Research, 1997
- Nociceptive responses to high and low rates of noxious cutaneous heating are mediated by different nociceptors in the rat: behavioral evidencePain, 1996
- Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activityPain, 1996
- Human Recombinant Nerve Growth Factor Replaces Deficient Neurotrophic Support in the Diabetic RatEuropean Journal of Neuroscience, 1995
- Formalin-induced nociceptive responses in diabetic miceNeuroscience Letters, 1993
- Evaluation of thermal and pain sensitivity in type I diabetic patients.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- Methodological refinements to the mouse paw formalin testJournal of Pharmacological Methods, 1988
- Efficient Analysis of Experimental ObservationsAnnual Review of Pharmacology and Toxicology, 1980